X

Xeris Biopharma Holdings
D

XERS

3.41000
USD
-0.07
(-2.01%)
Market Closed
Volume
0
EPS
-0
Div Yield
-
P/E
-8
Market Cap
508,367,782
OverviewSignalsIdeasNews
Related Instruments
    A
    ALDX
    -0.07500
    (-1.54%)
    4.79500 USD
    A
    AQST
    -0.06000
    (-1.64%)
    3.60000 USD
    B
    BHC
    0.03000
    (0.40%)
    7.48000 USD
    E
    EPIX
    0.03000
    (1.88%)
    1.63000 USD
    E
    ESPR
    0.05000
    (2.29%)
    2.23000 USD
    GILD
    GILD
    0.800
    (0.86%)
    93.370 USD
    I
    INSM
    0.100
    (0.14%)
    70.540 USD
    MRK
    MRK
    1.210
    (1.23%)
    99.360 USD
    R
    RDHL
    -0.12000
    (-1.85%)
    6.35000 USD
    S
    SAGE
    -0.18000
    (-3.21%)
    5.43000 USD
    More
News

Title: Xeris Biopharma Holdings

Sector: Healthcare
Industry: Biotechnology
Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome. The Company also has a pipeline of development programs to bring new products forward using its proprietary formulation science, XeriSol and XeriJect.